In order to see the efficacy of TILT-123 treatment alone or in combination with ICIs, ovarian cancer patient samples were infected with TILT-123 and/or treated with anti-PD-1/PD-L1 (Figure 1A,B). Here, PDCD1 is linked to ovarian carcinoma.